Single Versus Dual Implant Fixation of Distal Femur Fractures
NCT ID: NCT06286670
Last Updated: 2025-12-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
144 participants
INTERVENTIONAL
2024-09-16
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment of Proximal Humeral Fractures
NCT01246167
Single vs. Dual Implant Fixation for Distal Femur Fractures in Older or Compromised Adults
NCT06944964
Dual Implant Versus Single Implant Distal End of Femur
NCT05292313
Unipolar vs Bipolar Hemiarthroplasty for Hip Fracture
NCT06689579
Study on Outcomes of Proximal Humerus Fractures
NCT07060664
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single Implant Fixation
Single implant fixation with either a precontoured lateral locking plate or an intramedullary nail.
Single Implant Fixation
Single implant fixation with either a precontoured lateral locking plate or an intramedullary nail.
Dual Implant Fixation
Dual implant fixation with either a lateral locking plate plus an intramedullary nail or a lateral locking plate plus a supplemental medial plate.
Dual Implant Fixation
Dual implant fixation with either a lateral locking plate plus an intramedullary nail or a lateral locking plate plus a supplemental medial plate.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Single Implant Fixation
Single implant fixation with either a precontoured lateral locking plate or an intramedullary nail.
Dual Implant Fixation
Dual implant fixation with either a lateral locking plate plus an intramedullary nail or a lateral locking plate plus a supplemental medial plate.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Surgically treated displaced distal femur extra articular or complete articular fractures
Exclusion Criteria
* Patients unlikely to follow-up due to homelessness, or planning follow up at another institution
* Body Mass Index (BMI) \> 40
* Injury due to ground level fall
* Patient that speaks neither English or Spanish
* Patients with multisystem injuries that could preclude return to work
* \< 18 years of age
* Prisoner
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
United States Department of Defense
FED
Wake Forest University Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laurence Kempton, MD
Role: PRINCIPAL_INVESTIGATOR
Wake Forest University Health Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama Birmingham
Birmingham, Alabama, United States
Cedars-Sinai Medical Center
Los Angeles, California, United States
Emory University, Grady Memorial Research Hospital
Atlanta, Georgia, United States
Atrium Health Navicent
Macon, Georgia, United States
Louisiana State University
New Orleans, Louisiana, United States
University of Maryland, Shock Trauma Center
Baltimore, Maryland, United States
NYC Health and Hospital/Bellevue
New York, New York, United States
University of North Carolina Chapel Hill
Chapel Hill, North Carolina, United States
Atrium Health Carolinas Medical Center
Charlotte, North Carolina, United States
Atrium Health Cabarrus
Concord, North Carolina, United States
Pennsylvania State University
Hershey, Pennsylvania, United States
Prisma Health- Upstate
Greenville, South Carolina, United States
Vanderbilt University Medical Center
Nashville, Tennessee, United States
University of Texas Medical Branch
Galveston, Texas, United States
Inova
Fairfax, Virginia, United States
Valley Health
Winchester, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Geoffrey Marecek, MD
Role: primary
Jessica Rivera, MD
Role: primary
Mark Gage, MD
Role: primary
Nina Fisher, MD
Role: primary
Andrew Chen, MD
Role: primary
Kyle Jeray, MD
Role: primary
Phillip Mitchell, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HT94252311075
Identifier Type: OTHER
Identifier Source: secondary_id
IRB00108312
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.